Eli Lilly and Co LLY:NYSE

RT Quote | NYSE | USD
Last | 06/17/21 EDT
222.21quote price arrow up+1.45 (+0.66%)
Volume
1,812,796
52 week range
129.21 - 235.85

...

Loading . . .
  • Open220.27
  • Day High223.10
  • Day Low220.27
  • Prev Close222.21
  • 52 Week High235.85
  • 52 Week High Date06/10/21
  • 52 Week Low129.21
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap213.106B
  • Shares Out959.03M
  • 10 Day Average Volume5.14M
  • Dividend3.40
  • Dividend Yield1.53%
  • Beta0.24
  • YTD % Change31.61

KEY STATS

  • Open220.27
  • Day High223.10
  • Day Low220.27
  • Prev Close222.21
  • 52 Week High235.85
  • 52 Week High Date06/10/21
  • 52 Week Low129.21
  • 52 Week Low Date10/30/20
  • Market Cap213.106B
  • Shares Out959.03M
  • 10 Day Average Volume5.14M
  • Dividend3.40
  • Dividend Yield1.53%
  • Beta0.24
  • YTD % Change31.61

RATIOS/PROFITABILITY

  • EPS (TTM)6.68
  • P/E (TTM)33.28
  • Fwd P/E (NTM)27.52
  • EBITDA (MRQ)8.213B
  • ROE (MRQ)122.12%
  • Revenue (MRQ)25.486B
  • Gross Margin (MRQ)75.88%
  • Net Margin (MRQ)23.91%
  • Debt To Equity (MRQ)234.89%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date05/13/2021
  • Div Amount0.85
  • Split Date-
  • Split Factor-

Profile

MORE
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its...
David Ricks
Chairman
Anat Ashkenazi
Chief Financial Officer
Address
Lilly Corporate Ctr
Drop Code 1094, Lilly Corporate Ctr
Indianapolis, IN
46285-0001
United States

Top Peers

SYMBOLLASTCHG%CHG
AZN
AstraZeneca PLC
58.35-0.06-0.10%
NVS
Novartis AG
94.15UNCHUNCH
AMGN
Amgen Inc
240.76+1.18+0.49%
PFE
Pfizer Inc
39.48+0.18+0.46%
ABBV
Abbvie Inc
114.90-0.63-0.55%